Danaher Co. (NYSE:DHR) Shares Sold by ING Groep NV

ING Groep NV cut its holdings in Danaher Co. (NYSE:DHR) by 39.8% during the 3rd quarter, Holdings Channel.com reports. The institutional investor owned 85,964 shares of the conglomerate’s stock after selling 56,816 shares during the quarter. ING Groep NV’s holdings in Danaher were worth $23,900,000 at the end of the most recent reporting period.

Several other hedge funds have also recently added to or reduced their stakes in the business. CarsonAllaria Wealth Management Ltd. acquired a new position in Danaher in the 2nd quarter valued at $25,000. nVerses Capital LLC acquired a new position in shares of Danaher in the second quarter worth about $25,000. MFA Wealth Advisors LLC purchased a new stake in Danaher during the 2nd quarter worth approximately $51,000. Financial Connections Group Inc. bought a new position in shares of Danaher during the second quarter worth about $51,000. Finally, Western Pacific Wealth Management LP bought a new position in Danaher during the 1st quarter worth approximately $55,000. 79.05% of the stock is currently owned by hedge funds and other institutional investors.

Insider Transactions at Danaher

In other Danaher news, SVP Georgeann Couchara sold 952 shares of the company’s stock in a transaction on Monday, August 26th. The stock was sold at an average price of $268.37, for a total value of $255,488.24. Following the transaction, the senior vice president now owns 4,212 shares of the company’s stock, valued at $1,130,374.44. This represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Insiders own 11.10% of the company’s stock.

Danaher Price Performance

Shares of Danaher stock traded down $1.90 on Thursday, hitting $239.63. 804,589 shares of the company traded hands, compared to its average volume of 2,737,046. The firm’s 50-day simple moving average is $263.42 and its 200 day simple moving average is $260.64. Danaher Co. has a 12-month low of $204.15 and a 12-month high of $281.70. The company has a current ratio of 1.37, a quick ratio of 1.01 and a debt-to-equity ratio of 0.32. The company has a market cap of $173.08 billion, a P/E ratio of 46.08, a P/E/G ratio of 4.40 and a beta of 0.85.

Danaher (NYSE:DHR) last posted its earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.57 by $0.14. Danaher had a return on equity of 10.62% and a net margin of 16.39%. The company had revenue of $5.80 billion for the quarter, compared to analysts’ expectations of $5.59 billion. During the same period last year, the firm earned $2.02 earnings per share. Danaher’s quarterly revenue was up 3.1% on a year-over-year basis. Analysts expect that Danaher Co. will post 7.51 earnings per share for the current fiscal year.

Danaher Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, October 25th. Investors of record on Friday, September 27th were paid a dividend of $0.27 per share. The ex-dividend date of this dividend was Friday, September 27th. This represents a $1.08 annualized dividend and a yield of 0.45%. Danaher’s payout ratio is 20.61%.

Analyst Upgrades and Downgrades

DHR has been the subject of a number of research reports. Robert W. Baird decreased their price objective on shares of Danaher from $278.00 to $277.00 and set an “outperform” rating for the company in a report on Wednesday, October 23rd. Stifel Nicolaus upped their price target on Danaher from $250.00 to $265.00 and gave the company a “hold” rating in a research report on Wednesday, October 23rd. Raymond James reduced their price objective on Danaher from $310.00 to $300.00 and set an “outperform” rating for the company in a research report on Wednesday, October 23rd. Wolfe Research upgraded shares of Danaher from a “peer perform” rating to an “outperform” rating and set a $285.00 price target for the company in a report on Thursday, October 31st. Finally, Barclays reduced their price target on shares of Danaher from $285.00 to $275.00 and set an “equal weight” rating for the company in a report on Wednesday, October 23rd. Five analysts have rated the stock with a hold rating and fifteen have given a buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $287.16.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.